Association between physiotherapist sleep duration and working environment during the coronavirus disease 2019 pandemic in Japan: A secondary retrospective analysis study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306822 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Fumito Morisawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19, Physical Therapists, Sleep. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Studies have reported that health care professionals experienced a lack of sleep during the coronavirus disease 2019 (COVID-19) pandemic and that such lack of sleep and working environment affect their performance. However, to the authors’ knowledge, no study has yet investigated the relationship between sleep duration and working environment among Japanese physiotherapists during the COVID-19 pandemic. This study retrospectively investigated the sleep duration of physiotherapists directly providing physiotherapy to patients with COVID-19 within the red zone and analyzed the association between sleep duration and working environment using logistic regression analysis. Among the 565 physiotherapists studied, the average sleep duration was 6 (6–7) h, and 381 (67.4%) had an average sleep duration of ≤6 h. Less experienced physiotherapists were 1.03 times more likely to sleep ≤6 h, and those in charge of patients with COVID-19 as the supervisor ordered were 0.64 times more likely to sleep ≤6 h. Moreover, physiotherapists with a significant increase in the frequency of internal online meetings and those who had been providing physiotherapy to patients with COVID-19 for >6 months were 2.34 and 2.05 times more likely to sleep ≤6 h, respectively. During the COVID-19 pandemic in Japan, two-thirds of the physiotherapists directly providing physiotherapy to patients with COVID-19 slept less than the recommended duration. This study highlights the need for appropriate workload and work hour management for physiotherapists according to their experience and workload, as well as establishing a medical care system that includes work rotation to ensure that the recommended sleep duration is satisfied.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- Medical Japan, Pfizer Japan Inc., Tokyo, Japan.
- Division of Medical Education, Juntendo University School of Medicine, Tokyo, Japan.
- Medical Technology Innovation Center, Juntendo University, Tokyo, Japan.
- Clinical Research and Trial Center, Juntendo University, Tokyo, Japan.
- Faculty of Health Science, Juntendo University, Tokyo, Japan.
ORCID-Profile: Yuji Nishizaki, Tohru Minamino
Förderung
- Ministry of Health, Labour and Welfare
Zitieren
APA
Morisawa, F., Nishizaki, Y., Nojiri, S., Daida, H., Minamino, T., & Takahashi, T. (2024). Association between physiotherapist sleep duration and working environment during the coronavirus disease 2019 pandemic in Japan: A secondary retrospective analysis study. PLOS ONE. https://doi.org/10.1371/journal.pone.0306822
Vancouver
Morisawa F, Nishizaki Y, Nojiri S, Daida H, Minamino T, Takahashi T. Association between physiotherapist sleep duration and working environment during the coronavirus disease 2019 pandemic in Japan: A secondary retrospective analysis study. PLOS ONE. 2024. doi:10.1371/journal.pone.0306822
BibTeX
@article{Morisawa2024,
author = {Morisawa, Fumito and Nishizaki, Yuji and Nojiri, Shuko and Daida, Hiroyuki and Minamino, Tohru and Takahashi, Tetsuya},
title = {Association between physiotherapist sleep duration and working environment during the coronavirus disease 2019 pandemic in Japan: A secondary retrospective analysis study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306822}
}
EUVIMED